Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis
about
Prevention of stress-related ulcer bleeding at the intensive care unit: Risks and benefits of stress ulcer prophylaxisWhat is the optimum prophylaxis against gastrointestinal haemorrhage for patients undergoing adult cardiac surgery: histamine receptor antagonists, or proton-pump inhibitors?Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategiesPrevention of hospital-acquired pneumonia in non-ventilated adult patients: a narrative review25 Years of Proton Pump Inhibitors: A Comprehensive Review.Widespread use of gastric acid inhibitors in infants: Are they needed? Are they safe?Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control studyCommunity acquired pneumonia incidence before and after proton pump inhibitor prescription: population based studyAnti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.Perils and pitfalls of long-term effects of proton pump inhibitors.A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors.Cost Effectiveness of Gastroprotection with Proton Pump Inhibitors in Older Low-Dose Acetylsalicylic Acid Users in the Netherlands.Infection-related asthma.Risk of fracture and pneumonia from acid suppressive drugs.Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis.Factors associated with the initiation of proton pump inhibitors in corticosteroid users.Effects of proton pump inhibitors on lung cancer precise radiotherapy-induced radiation pneumonitisCharacteristics and outcomes of patients hospitalized following pulmonary aspiration.Evidence-based assessment of proton-pump inhibitors in Helicobacter pylori eradication: a systematic review.Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea.Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugs.Proton pump inhibitors: Are we still prescribing them without valid indications?Advances in the evaluation and management of esophageal disease of systemic sclerosis.Proton pump inhibitors and the risk of pneumonia: a comparison of cohort and self-controlled case series designsPrescribing efficiency of proton pump inhibitors in China: influence and future directionsProton pump inhibitor-associated pneumonia: Not a breath of fresh air after all?The impact of acid-suppressing drugs to the patients with chronic obstructive pulmonary disease: A nationwide, population-based, cohort study.Multimorbidities and Overprescription of Proton Pump Inhibitors in Older PatientsPotential protective effects of Clostridium butyricum on experimental gastric ulcers in miceOut-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control studyInhibition of Gastric Acid Secretion by H2 Receptor Antagonists Associates a Definite Risk of Enteric Peritonitis and Infectious Mortality in Patients Treated with Peritoneal Dialysis.Adverse Event Reporting for Proton Pump Inhibitor Therapy: An Overview of Systematic Reviews.Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysisThe Indications, Applications, and Risks of Proton Pump InhibitorsProton Pump Inhibitors Did Not Increase Risk of Pneumonia in Patients With Chronic Obstructive Pulmonary Disease.eComment. The evidence for stress ulcer prophylaxis in patients undergoing cardiac surgery.Histamine H2-Blocker and Proton Pump Inhibitor Use and the Risk of Pneumonia in Acute Stroke: A Retrospective Analysis on Susceptible PatientsDUEXIS(®) (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug.
P2860
Q26768234-24C2956A-7C6A-46FA-B2E1-D7D59815CCE2Q27025253-48FE5E96-A65C-493A-BC9E-E78AB93CF8F3Q27026351-7A34E642-B5AF-4EE5-8855-9A5B9A710529Q28069165-950AA936-1CB3-48E9-840E-F6FCD98F98FDQ28070003-3E95987A-B6CA-4A3D-A0BE-CC8CE386FF96Q28072141-F04EA3CC-2853-46CA-A68A-E0F3A0503640Q28543390-E6ED27ED-822D-483B-BDD4-3105A53CAC68Q28595726-06691678-0D54-4FA6-BFE5-625C17478EDFQ30412203-08062579-ADED-41D9-9936-3FD187193456Q33409626-DC115103-5A5C-462F-92A8-457A5E7B13B4Q33441225-8DD35C9D-D011-46C4-B326-426B4ACE6DF6Q33611577-8710C638-C02C-418A-9D84-996ACCA2669AQ33917155-77E6D205-0844-414C-B255-6073CF06E45CQ34092977-6B6B158D-418E-4B62-A173-B6A1C6C69687Q34127482-465ADF3B-A0FB-4DAB-9D57-991F1A8760FAQ34132829-0AD172D5-562A-484A-A5F3-C3B8C90BDD74Q34141425-85D0E4AA-3F39-4E4D-9289-A9037E05CC87Q34277926-B18E1DB9-B945-43BD-ABD9-02F447972697Q34299812-2BEB0D74-0911-437A-8500-575E94007E2AQ34404967-CE67EB62-2571-4935-B653-140EB7B6EB77Q34479280-AE0CCAE9-00B3-4E63-A50D-121B42AB33F6Q34487166-7B97E821-D7DB-46A9-947B-49919184F18CQ34636475-0BBBEFCD-ABB6-4BD5-8EFC-9620EA595B1FQ34652739-26B316CC-136E-4054-AD24-F07C05C78350Q34666835-37D30A59-682B-4DDA-B363-9699675B8377Q34783099-5955D355-0DBE-4060-91CF-2CE2D07679C2Q35021173-587EF440-FA59-4E9D-BB6F-30D55C05B2F6Q35072261-44263E3F-F789-4CD8-9340-C601987106CFQ35744820-FBCC5A8F-8C4F-40A5-957B-4E8AFBE6ECE8Q35831677-63452DBF-0F4D-4FE9-9C9C-978EBE7F83C7Q35865246-135A63D1-4AEE-4E6A-A78B-D55FA8888D15Q35899886-58854364-5CF0-4C13-963E-7D54042A2FA7Q35922573-E47E6B1C-41E6-4831-B971-9BA0B2ED67EDQ36020285-C7D63591-B8A3-4925-9247-82A91183EBD3Q36089280-0DBB1BBD-6684-459F-887F-A893359F6ECCQ36091187-6E45334B-A951-4021-9D07-DF90584675BFQ36130637-A04DF40D-D78A-4255-9445-69EE1B579F24Q36168618-33D4C037-C9AA-435A-8382-FF9AE96C411AQ36248841-9A482B35-2032-426C-BAA1-CB9559280C02Q36280849-1268C92C-1894-4B0D-A2B3-628E6D0154A5
P2860
Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Use of acid-suppressive drugs ...... matic review and meta-analysis
@ast
Use of acid-suppressive drugs ...... matic review and meta-analysis
@en
Use of acid-suppressive drugs ...... matic review and meta-analysis
@en-gb
Use of acid-suppressive drugs ...... matic review and meta-analysis
@nl
type
label
Use of acid-suppressive drugs ...... matic review and meta-analysis
@ast
Use of acid-suppressive drugs ...... matic review and meta-analysis
@en
Use of acid-suppressive drugs ...... matic review and meta-analysis
@en-gb
Use of acid-suppressive drugs ...... matic review and meta-analysis
@nl
prefLabel
Use of acid-suppressive drugs ...... matic review and meta-analysis
@ast
Use of acid-suppressive drugs ...... matic review and meta-analysis
@en
Use of acid-suppressive drugs ...... matic review and meta-analysis
@en-gb
Use of acid-suppressive drugs ...... matic review and meta-analysis
@nl
P2093
P2860
P31
P3181
P356
P1476
Use of acid-suppressive drugs ...... matic review and meta-analysis
@en
P2093
Christie Y Jeon
Chun-Sick Eom
Eun-Geol Cho
Ju-Won Lim
Kang-Sook Lee
Sang Min Park
P2860
P3181
P356
10.1503/CMAJ.092129
P407
P577
2011-02-22T00:00:00Z